Literature DB >> 3356738

Dimethylsulfoxide with heparin in the treatment of smoke inhalation injury.

M Brown1, M Desai, L D Traber, D N Herndon, D L Traber.   

Abstract

Recent studies suggest that lung lesions occurring in inhalation injury result from actions of oxygen-free radicals released from polymorphonuclear leukocytes marginating in the pulmonary microcirculation and tracheobronchial region. Peroxide and hydroxyl ions have been implicated as mediators in the increased microvascular permeability and pulmonary edema noted after inhalation injury. In this study we evaluated the use of an O2-free radical scavenger, dimethylsulfoxide (DMSO), and heparin in the treatment of smoke inhalation. Ewes (N = 26) that had been surgically prepared five days earlier were insufflated with smoke from burning cotton. There were four groups: controls (n = 7), DMSO (n = 6), heparin (n = 6), and DMSO plus heparin (n = 7). All animals were given ventilatory support to maintain their PO2 above 60 mmHg and their PCO2 below 45 mmHg. There was a significant difference in survival rates between groups. By 72 hours all seven of the control group were dead. All animals in the DMSO plus heparin group survived, four of the DMSO group died, and two of the heparin group died. Lung lymph flow was not as high in the DMSO plus heparin group as in the heparin-only group. DMSO was proved effective in reducing the lung injury associated with smoke inhalation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356738     DOI: 10.1097/00004630-198801000-00007

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  10 in total

1.  Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury.

Authors:  Marcus J Schultz; Marcel Levi
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

Review 2.  The cornerstones and directions of pediatric burn care.

Authors:  S E Wolf; M Debroy; D N Herndon
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

3.  Progress in burns research: a review of advances in burn pathophysiology.

Authors:  P I Jewo; I O Fadeyibi
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

Review 4.  Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.

Authors:  Andrew C Miller; Elamin M Elamin; Anthony F Suffredini
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

5.  Pathophysiology, management and treatment of smoke inhalation injury.

Authors:  Sebastian Rehberg; Marc O Maybauer; Perenlei Enkhbaatar; Dirk M Maybauer; Yusuke Yamamoto; Daniel L Traber
Journal:  Expert Rev Respir Med       Date:  2009-06-01       Impact factor: 3.772

Review 6.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 7.  Pathophysiology, research challenges, and clinical management of smoke inhalation injury.

Authors:  Perenlei Enkhbaatar; Basil A Pruitt; Oscar Suman; Ronald Mlcak; Steven E Wolf; Hiroyuki Sakurai; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

8.  Pharmaco-management of inhalation injuries for burn survivors.

Authors:  Anthony C Bartley; Dale W Edgar; Fiona M Wood
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

9.  Management of burn injuries--recent developments in resuscitation, infection control and outcomes research.

Authors:  David J Dries
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-03-11       Impact factor: 2.953

Review 10.  Diagnosis and management of inhalation injury: an updated review.

Authors:  Patrick F Walker; Michelle F Buehner; Leslie A Wood; Nathan L Boyer; Ian R Driscoll; Jonathan B Lundy; Leopoldo C Cancio; Kevin K Chung
Journal:  Crit Care       Date:  2015-10-28       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.